Asset Details
Do you wish to reserve the book?
Distribution and pharmacological characterization of primate NK‐1 and NK‐3 tachykinin receptors in the central nervous system of the rhesus monkey
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Distribution and pharmacological characterization of primate NK‐1 and NK‐3 tachykinin receptors in the central nervous system of the rhesus monkey
Do you wish to request the book?
Distribution and pharmacological characterization of primate NK‐1 and NK‐3 tachykinin receptors in the central nervous system of the rhesus monkey
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Distribution and pharmacological characterization of primate NK‐1 and NK‐3 tachykinin receptors in the central nervous system of the rhesus monkey
2006
Overview
Much attention has focused on tachykinin receptors as therapeutic targets for neuropsychiatric disorders, although their expressional distributions in the primate central nervous system (CNS) remain unclear. We cloned the genes encoding the NK‐1 and NK‐3 tachykinin receptors (referred to as rmNK‐1 and rmNK‐3) from the rhesus monkey (Macaca mulatta) brain and examined their pharmacological profiles and regional distributions in the CNS. The deduced rmNK‐1 amino‐acid sequence differed by only two amino acids from the human NK‐1 (hNK‐1). The deduced rmNK‐3 amino‐acid sequence was two amino acids shorter than human NK‐3 (hNK‐3), with a seven‐amino‐acid difference in sequence. Ligand binding studies revealed that the affinity of rmNK‐1 to substance P (SP) was comparable to that of hNK‐1 in cell lines that expressed individual receptors stably. Nonpeptide antagonists had similar effects on the binding of rmNK‐1 and hNK‐1. Affinity of rmNK‐3 for NKB was stronger than for SP and the IC50 value was comparable with that of hNK‐3. Ca2+ imaging showed that activations of both rmNK‐1 and rmNK‐3 by specific ligands, SP and senktide, induced increased intracellular Ca2+ in cell lines that stably expressed individual primate tachykinin receptors. The amounts of rmNK‐1 and rmNK‐3 mRNAs were quantitatively determined in the monkey CNS. The expression of rmNK‐1 was observed in all of the cortical and subcortical regions, including the hippocampus and the amygdala. The putamen contained the most NK‐1 mRNA in the brain, with less rmNK‐3 mRNA found in the cortex compared to rmNK‐1 mRNA. In the monkey hippocampus and amygdala, rmNK‐1 mRNA was present at markedly higher concentrations than rmNK‐3 mRNA. The present results provide an insight into the distinct physiological nature and significance of the NK‐1 and NK‐3 tachykinin systems in the primate CNS. These findings are indispensable for establishing model systems in the search for a subtype‐specific tachykinin receptor agonist and antagonist for the treatment of neuropsychiatric disorders. British Journal of Pharmacology (2006) 147, 316–323. doi:10.1038/sj.bjp.0706561
Publisher
Blackwell Publishing Ltd,Nature Publishing,Nature Publishing Group
Subject
/ Amygdala
/ Animals
/ Biological and medical sciences
/ CNS
/ Humans
/ Male
/ NK‐1
/ NK‐3
/ Pharmacology. Drug treatments
/ primate
/ Receptors, Neurokinin-1 - analysis
/ Receptors, Neurokinin-1 - drug effects
/ Receptors, Neurokinin-1 - genetics
/ Receptors, Neurokinin-3 - analysis
/ Receptors, Neurokinin-3 - drug effects
